View the ZYNOMAX POWDER FOR ORAL SUSPENSION 200 MG/5 ML registration information details.
Back to drug list
ItemsDrug Registration information
ID615
No615
Brand NameZYNOMAX POWDER FOR ORAL SUSPENSION 200 MG/5 ML
IngredientsAZITHROMYCIN DIHYDRATE EQ.TO AZITHROMYCIN 200 MG/5ML
Dosage FormPOWDER FOR ORAL SUSPENSION
Primary PackagingBOTTLE
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 20 ML/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR INFECTION CAUSED BY SUSCEPTIBLE ORGANISMS; IN LOWER RESPIRATORY TRACT INFECTION INCLUDING BRONCHITIS AND PNEUMONIA, IN SKIN AND SOFT TISSUE INFECTION, IN ACUTE OTITIS MEDIA AND IN UPPER RESPIRATORY TRACT INFECTION INCLUDING SINUSITIS AND PHARYNGITIS/TONSILLITIS. IN SEXUALLY TRANSMITTED DISEASES IN MEN AND WOMEN, TREATMENT OF UNCOMPLICATED GENITAL INFECTION DUE TO CHLAMYDIA TRACHOMATIS.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE TO OFF WHITE HOMOGENOUS GRANULES, ON RECONSTITUTION WITH WATER, WHITE TO OFF WHITE WITH TUTTY FRUITY FLAVOURED HOMOGENOUS SUSPENSION
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerDUOPHARMA MANUFACTURING (BANGI) SDN.BHD.
CountryMALAYSIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 I 5484/23
FDD Registration Date25/04/2023
Expiry Date24/04/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA